<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-biomolecules-10-01625">
 <label>59.</label>
 <element-citation publication-type="patent">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>B.Y.</given-names>
   </name>
   <name>
    <surname>Cho</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.G.</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Heterocyclic Compounds, Preparation Methods, Pharmaceutical Compositions, and Use as Prolyl-tRNA Synthetase Inhibitors</article-title>
  <source>International Patent</source>
  <patent>WO 2018147626 A1</patent>
  <comment>Korean Patent KR102084772B1; Australian Patent AU2018218965B2</comment>
  <day>16</day>
  <month>8</month>
  <year>2018</year>
 </element-citation>
</ref>
